ScripAustralian biotechs Certa Therapeutics and OccuRx are combining their assets under one company in a bid to become a leading player in the fibrotic diseases space. Certa’s acquisition of fellow Melbo
In VivoIn April 2024 Citeline’s Scrip publication reviewed the internal and external R&D inputs of the top 15 companies by sales of prescription and over-the-counter drugs in 2023. This analysis reve
ScripPrivately held Soterios Pharma unveiled positive top-line Phase II data for its alopecia areata candidate STS-01 on 30 May, saying the drug could be positioned to compete with established JAK inhibi
In VivoMonica Shaw joined Bristol Myers Squibb Company as head of major markets in September. Based in Zurich, she is senior vice president and head of European markets, overseeing 22 countries – the compa